血清脂联素对西宁地区胃癌患者的诊断价值研究

纪荣祖, 常璠, 刘春艳. 血清脂联素对西宁地区胃癌患者的诊断价值研究[J]. 中国中西医结合消化杂志, 2019, 27(8): 572-577. doi: 10.3969/j.issn.1671-038X.2019.08.03
引用本文: 纪荣祖, 常璠, 刘春艳. 血清脂联素对西宁地区胃癌患者的诊断价值研究[J]. 中国中西医结合消化杂志, 2019, 27(8): 572-577. doi: 10.3969/j.issn.1671-038X.2019.08.03
JI Rong-zu, CHANG Fan, LIU Chun-yan. Diagnostic value of serum adiponectin in patients with gastric cancer in Xining[J]. Chin J Integr Tradit West Med Dig, 2019, 27(8): 572-577. doi: 10.3969/j.issn.1671-038X.2019.08.03
Citation: JI Rong-zu, CHANG Fan, LIU Chun-yan. Diagnostic value of serum adiponectin in patients with gastric cancer in Xining[J]. Chin J Integr Tradit West Med Dig, 2019, 27(8): 572-577. doi: 10.3969/j.issn.1671-038X.2019.08.03

血清脂联素对西宁地区胃癌患者的诊断价值研究

  • 基金项目:

    西宁市科技项目(No:2014-K-10)

详细信息
    作者简介:

    纪荣祖,男,本科,副主任技师,研究方向:生化检验及免疫检验

    通讯作者: 纪荣祖,E-mail:437348029@qq.com
  • 中图分类号: R735.2

Diagnostic value of serum adiponectin in patients with gastric cancer in Xining

More Information
  • [目的]评价血清脂联素对西宁地区胃癌患者的诊断价值研究。[方法]选择2016年1月~2018年6月在我院就诊的胃癌患者60例作为研究对象,再选择同期就诊的胃良性疾病患者100例和健康体检人群110例作为对照组,比较3组血清脂联素、CEA、CA19-9和CA72-4水平,再根据受检者是否合并Hp感染进行分组比较,使用ROC曲线评价各指标对胃癌的诊断效能。[结果]胃癌组脂联素水平低于健康对照、胃良性疾病组(P<0.01),CEA、CA19-9、CA72-4水平高于健康对照组、胃良性疾病组(P<0.01);幽门螺杆菌(Hp)感染者胃癌组脂联素低于健康对照、胃良性疾病组(P<0.01),胃癌组血清CEA,CA19-9,CA72-4水平高于健康对照组、胃良性疾病组(P<0.01);未感染Hp者胃癌组脂联素水平低于健康对照组、胃良性疾病组(P<0.01),胃良性疾病组CEA、CA19-9、CA72-4水平高于健康对照组(P<0.01),胃癌组CEA、CA72-4水平高于胃良性疾病组(P<0.01),胃癌组CA72-4高于健康对照组(P<0.01);Hp感染胃癌患者CEA、CA19-9、CA72-4水平高于未感染组(P<0.01),而血清脂联素水平差异无统计学意义;单项检测时脂联素的ROC曲线下面积(AUC)最高,后续依次为CA72-4、CEA、CA19-9,联合检测时AUC高于单项检测。[结论]脂联素诊断效能高于CEA、CA19-9、CA72-4,而且Hp感染不影响脂联素的诊断效能,4项指标联合检测可大大提高对胃癌早期诊断的准确率。
  • 加载中
  • [1]

    Casamayor M, Morlock R, Maeda H, et al.Targeted literature review of the global burden of gastric cancer[J].Ecancermedicalscience, 2018, 26 (12):883.

    [2]

    Panarese I, De Vita F, Ronchi A, et al.Predictive biomarkers along gastric cancer pathogenetic pathways[J].Expert Rev Anticancer Ther, 2017, 17 (5):417-425.

    [3]

    Ayyildiz T, Dolar E, Ugras N, et al.Lack of any prognostic relationship between adiponectin receptor (Adipo R1/R2) expression for early/advanced stage gastric cancer[J].Asian Pac J Cancer Prev, 2014, 15 (11):4711-4716.

    [4]

    Lai H, Jin Q, Lin Y, et al.Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer[J].Tumour Biol, 2014, 35 (10):10547-10554.

    [5]

    Epplein M, Butt J, Zhang Y, et al.Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer[J].Cancer Epidemiol Biomarkers Prev, 2018, 27 (12):1472-1479.

    [6]

    Yu J, Zheng W.An Alternative Results for Screening Gastric Cancer Based on Serum Levels of CEA, CA19-9, and CA72-4[J].J Gastrointest Cancer, 2018, 49 (1):57-62.

    [7]

    Pan Q, Law COK, Yung MMH, et al.Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50and CA72-4with superior affinity and specificity[J].PLoS One, 2018, 13 (10):e0198980.

    [8]

    Feng F, Tian Y, Xu G, et al.Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125for early gastric cancer[J].BMC Cancer, 2017, 17 (1):737.

    [9]

    江冬莲, 曹仕琼, 江燕莉, 等.华蟾素胶囊联合XELOX方案治疗晚期胃癌临床疗效及对患者免疫状态和血清CEA、CA19-9、MMP-14水平的影响[J].中国中西医结合消化杂志, 2018, 26 (9):778-782.

    [10]

    江唯波, 陈淼, 虞信维.血清胃蛋白酶原、CEA、CA199、CA724与胃泌素17联合检测在胃癌早期诊断中的应用价值分析[J].中国中西医结合消化杂志, 2017, 25 (11):833-836.

    [11]

    Wang SL, Yu GY, Yao J, et al.Diagnostic role of carbohydrate antigen 72-4for gastrointestinal malignancy screening in Chinese patients:A prospective study[J].J Dig Dis.2018, 19 (11):685-692.

    [12]

    Plummer M, Franceschi S, Vignat J, et al.Global burden of gastric cancer attributable to Helicobacter pylori[J].Int J Cancer, 2015, 136 (2):487-490.

    [13]

    Abbas M, Ahmed A, Khan GJ, et al.Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer[J].Curr Probl Cancer, 2019, 43 (1):5-17.

    [14]

    Kishida K, Funahashi T, Shimomura I.Adiponectin as a routine clinical biomarker[J].Best Pract Res Clin Endocrinol Metab, 2014, 28 (1):119-130.

    [15]

    Xu MY, Cao B, Chen Y, et al.Association between Helicobacter pylori infection and tumor markers:an observational retrospective study[J].BMJ Open, 2018, 8 (8):e022374.

  • 加载中
计量
  • 文章访问数:  158
  • PDF下载数:  122
  • 施引文献:  0
出版历程
收稿日期:  2019-03-06

目录